Current Smoker: Clinical Trials

1 trial for Current Smoker, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Terminated 1

Follow Current Smoker: new trials by email Literature Review of Current Smoker trials Research Report on Current Smoker

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Bupropion Hydrochloride, Laboratory Biomarker Analysis, Nicotine Replacement - Current Smoker, Head and Neck Squamous Cell Carcinoma
Early Phase 1TerminatedWake Forest University Health Sciences92016-01-012023-03-22

Narrower conditions

Nasopharyngeal Carcinoma (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Broader conditions

Carcinoma (1)  ·  Carcinoma, Squamous Cell (1)  ·  Head and Neck Neoplasms (1)  ·  Nasopharyngeal Diseases (1)  ·  Nasopharyngeal Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Otorhinolaryngologic Neoplasms (1)  ·  Pharyngeal Diseases (1)  ·  Pharyngeal Neoplasms (1)  ·  Stomatognathic Diseases (1)

Interventions

Bupropion (1)  ·  Nicotine Replacement Therapy (1)  ·  Varenicline (1)

Sponsors

Wake Forest University Health Sciences (1)

Countries

United States (1)

Top investigators

Mercedes Porosnicu (1)

Results publications

PMID 33605440

NIH funding

P30CA012197 (1)